Open AccessAbstract 1555: Single cell level treatment-specific characterization of HER2+ breast cancers treated with immune checkpoint inhibitors and entinostat
Author(s) -
Dimitrios N. Sidiropoulos,
Emily F. Davis-Marcisak,
Christine I. Rafie,
Luciane T. Kagohara,
Gaurav Sharma,
Roisín M. Connolly,
Vered Stearns,
Srinivasan Yegnasubramanian,
Elizabeth M. Jaffee,
Elana J. Fertig,
Evanthia T. Roussos Torres
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-1555
Subject(s) - tumor microenvironment , cancer research , immunotherapy , histone deacetylase inhibitor , immune system , cytotoxic t cell , antigen , immune checkpoint , cancer , vorinostat , medicine , histone deacetylase , epigenetics , immunology , t cell , biology , histone , biochemistry , in vitro , gene